|
KIAA0907 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.014600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.104600E-01 |
| Normal-vs-Stage2 |
2.083900E-03 |
| Normal-vs-Stage3 |
7.240800E-01 |
| Normal-vs-Stage4 |
2.008000E-01 |
| Stage1-vs-Stage2 |
1.416250E-03 |
| Stage1-vs-Stage3 |
8.401200E-01 |
| Stage1-vs-Stage4 |
1.023240E-01 |
| Stage2-vs-Stage3 |
3.195900E-03 |
| Stage2-vs-Stage4 |
2.619300E-04 |
| Stage3-vs-Stage4 |
8.514500E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.770200E-01 |
| Normal-vs-AfricanAmerican |
8.675000E-01 |
| Normal-vs-Asian |
5.090200E-01 |
| Caucasian-vs-AfricanAmerican |
8.886400E-01 |
| Caucasian-vs-Asian |
4.928000E-01 |
| AfricanAmerican-vs-Asian |
7.084600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.893600E-01 |
| Normal-vs-Female |
4.478600E-01 |
| Male-vs-Female |
6.177700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.589800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.395000E-01 |
| Normal-vs-Age(61-80Yrs) |
6.138800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.595400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.188800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.850000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.409600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.601600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.488800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.033400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.578650E-01 |
| Classical-VS-Follicular |
2.28606023000566E-12 |
| Classical-VS-Other |
4.928000E-01 |
| Classical-VS-Normal |
3.434200E-01 |
| Tall-VS-Follicular |
1.240410E-03 |
| Tall-VS-Other |
1.511770E-01 |
| Tall-VS-Normal |
7.096400E-01 |
| Follicular-VS-Other |
1.160100E-03 |
| Follicular-VS-Normal |
3.94380000000583E-05 |
| Other-VS-Normal |
2.440000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.889600E-02 |
| Normal-vs-N1 |
1.848240E-02 |
| N0-vs-N1 |
1.178400E-04 |
|
|
